BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 1, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 23, 2001
View Archived Issues
Immune response boosted by MVA-BN melanoma vaccine
Read More
MedImmune and Genaera establish anti-IL-9 antibody collaboration
Read More
Samaritan to acquire exclusive worldwide rights to Georgetown technologies
Read More
Gem Pharmaceuticals develops noncardiotoxic anthracycline antitumor agents
Read More
Newly synthesized cognition-enhancing agent ZSET-845 presented at Kyoto meeting
Read More
Topoisomerase I and II inhibitor conjugates jointly designed by U.S. universities
Read More
Banyu's new antidiabetic/antiobesity agents increase GLP-1 levels
Read More
Pharming acquires ProBio
Read More
Research at Ligand leads to identification of androgen receptor modulators
Read More
Nicotinic cholinergic receptor agonists selective for brain receptors discovered at Targacept
Read More
Vanderbilt researchers patent selective new adenosine A2B antagonists
Read More
Urokinase inhibitors synthesized at Abbott; compositions and methods of use described
Read More
Abbott describes use of new GR antagonists in diabetes Rx
Read More
Lion Bioscience reaches milestone in drug target alliance with Bayer
Read More
Proglutathione antioxidant with potential for reducing side effects of NRTI and in neuroAIDS Rx
Read More
Patient dosing begins in phase I trial of intravenous IL-2 gene medicine
Read More
Selective inhibitor of SGLT-2 synthesized at Kissei useful for the treatment of diabetes
Read More
Cotara enters additional trial for liver cancer
Read More
Use of cariporide in liver fibrosis discussed at EASL meeting
Read More
Low-dose Climara approved by FDA as starting dose for menopausal symptoms
Read More
Vical discontinues current Leuvectin trial in kidney cancer and plans new trial
Read More
L-dT safe and effective in patients with chronic HBV infection according to preliminary data
Read More
Potent and selective anti-HIV agents disclosed at recent Japanese scientific conference
Read More
Gastric prokinetic agents with a quinazoline structure in development at Kyowa Hakko
Read More
Naja venom fraction induces apoptosis in human leukemia cells
Read More
Singulair approved for treatment of children with asthma as young as two years
Read More
Novel memory-enhancing technology licensed by Axonyx from TJU
Read More
DuPont releases structures of new HIV protease inhibitors DPC-681, DPC-684
Read More